Ribometrix
Greenville
About Ribometrix
Ribometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $45.3M
- Last round: Series Unknown (Sep 2019)
- Website: ribometrix.com
- Phone: (252) 551-1088
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ribometrix-42477 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.